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Food intake and body weight regulation depend on proper expres-
sion of the proopiomelanocortin gene (Pomc) in a group of neurons
located in the mediobasal hypothalamus of all vertebrates. These
neurons release POMC-encoded melanocortins, which are potent an-
orexigenic neuropeptides, and their absence from mice or humans
leads to hyperphagia and severe obesity. Although the pathophysi-
ology of hypothalamic POMC neurons is well understood, the genetic
program that establishes the neuronal melanocortinergic phenotype
and maintains a fully functional neuronal POMC phenotype through-
out adulthood remains unknown. Here, we report that the early
expression of the LIM-homeodomain transcription factor Islet 1 (ISL1)
in the developing hypothalamus promotes the terminal differentiation
of melanocortinergic neurons and is essential for hypothalamic Pomc
expression since its initial onset and throughout the entire lifetime.We
detected ISL1 in the prospective hypothalamus just before the onset of
Pomc expression and, from then on, Pomc and Isl1 coexpress. ISL1
binds in vitro and in vivo to critical homeodomain binding DNAmotifs
present in the neuronal Pomc enhancers nPE1 and nPE2, and muta-
tions of these sites completely disrupt the ability of these enhancers to
drive reporter gene expression to hypothalamic POMC neurons in
transgenic mice and zebrafish. ISL1 is necessary for hypothalamic Pomc
expression during mouse and zebrafish embryogenesis. Furthermore,
conditional Isl1 inactivation from POMC neurons impairs Pomc expres-
sion, leading to hyperphagia and obesity. Our results demonstrate that
ISL1 specifies the identity of hypothalamic melanocortin neurons and
is required for melanocortin-induced satiety and normal adiposity
throughout the entire lifespan.
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Regulation of body weight and energy balance in vertebrateanimals is controlled by hypothalamic circuits that integrate
environmental, peripheral, and central signals to promote food in-
take or satiety (1). In particular, a set of neurons located in the
arcuate nucleus of the hypothalamus expresses proopiomelanocortin
(Pomc), a gene that encodes the anorexigenic melanocortins α-,
β- and γ-melanocyte-stimulating hormone (MSH). POMC neurons
sense leptin, insulin and glucose levels, and receive multiple syn-
aptic contacts which, together, orchestrate neuronal activity and
determine the pattern of melanocortins release (2, 3). The physi-
ological relevance of the central melanocortin system can be readily
appreciated in hypothalamic Pomc-deficient mice, which are hy-
perphagic and display early onset severe obesity (4). In addition,
humans carrying biallelic null POMC variants are also severely
obese (5). Although much has been learned about the physiology of
central melanocortinergic neurons and the pathological con-
sequences of their malfunction, the genetic programs that de-
termine the phenotypic identity of these neurons and maintain the
neuronal POMC phenotype throughout the entire lifespan remain
to be explored. A unique feature that specifies the neuronal mel-
anocortinergic phenotype is, in fact, the expression of Pomc because
other genes necessary for POMC processing and melanocortin re-
lease are common to most other neurons expressing neuropeptide
brain genes. Cotransmitters such as glutamate, GABA, or cocaine-
and amphetamine-regulated transcript (CART) are found only
in fractions of hypothalamic POMC neurons (6, 7), as are leptin,
insulin, estrogen, and serotonin receptors (8–10).
It has been shown, first in the invertebrate worm Caenorhabditis
elegans, that the identity of a neuronal type is specified early in
development by the expression of a specific transcription factor
(TF) that promotes terminal differentiation of postmitotic neu-
rons into their final functional phenotype (11). A TF acting on
terminal specification binds to cis-acting regulatory motifs present
in target genes that determine the neurotransmitter phenotype
and may continue later in life maintaining the same postmitotic
identity (11). A similar scenario has been found more recently in
vertebrates, after the identification of the genetic programs that
give birth and maintain serotonergic (12), dopaminergic (13), and
noradrenergic neurons (14) in the mouse nervous system. Less
is known, however, about the specification of neuronal types
expressing neuropeptide genes.
Transcriptional regulation of Pomc in the hypothalamus is con-
veyed by a distal upstream regulatory cis-acting module that contains
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two enhancers, named “neuronal Pomc enhancers” (nPE1 and nPE2),
which are highly conserved in mammals (15). Expression studies in
transgenic mice showed that nPE1 and nPE2 drive completely
overlapping spatiotemporal enhancer activities to the ∼3,000
POMC neurons present in the mouse ventromedial hypothalamus
during embryogenesis as well as in adulthood (16) and only the
concurrent removal of both enhancers from the mouse Pomc locus
by targeted mutagenesis reduced Pomc expression to very low
levels, leading to hyperphagia and early-onset obesity (17). Inter-
estingly, nPE1 and nPE2 are unrelated sequences with distinct
evolutionary origins; whereas nPE2 is derived from the exaptation
(cooption) of a CORE-short interspersed nuclear element (SINE)
retroposon in the lineage leading to mammals more than 166 mil-
lion years ago (Mya) (18), nPE1 is a placental mammal novelty
derived from the exaptation of a LTR-containing a mammalian ap-
parent LTR retroposon that occurred between 150 and 90 Mya (16).
We have recently identified conserved C/ATTA motifs that
might be recognized by homeodomain-containing transcription
factors (HDTFs) within nPE2 and nPE1, which are essential for
driving reporter gene expression to POMC neurons (17). Because
nPE1 and nPE2 are functional analogs, it is conceivable that these
sequences recruit a common, yet unidentified TF able to trans-
activate Pomc in the hypothalamus. Pomc expression starts in the
ventral lining of the developing mouse hypothalamus at embryonic
day 10.5 (E10.5) (15–17), a precise spatiotemporal domain in
which multiple HDTFs determine the early patterning of the
mouse ventral hypothalamus (19, 20). Therefore, we considered of
interest to investigate whether the terminal differentiation of
melanocortin-expressing neurons is regulated by a HDTF.
In this study we used a combination of bioinformatic, molecular,
genetic, and evolutionary approaches that led to the identification
of the LIM-homeodomain TF Islet 1 (ISL1) as a crucial regulator
of the terminal specification of melanocortinergic neurons in the
vertebrate hypothalamus by interacting with specific ISL1 binding
motifs present in two neuronal enhancers of Pomc. Furthermore,
our results demonstrate that Isl1 expression is necessary to
maintain elevated levels of hypothalamic Pomc mRNA in adult
mice to assure normal food intake and body weight regulation.
Results
ISL1 Is a Candidate TF to Regulate Hypothalamic Pomc Expression.
Previously, we found six putative HDTF binding sites in critical
regions of nPE2 and three in the 144-bp core region of nPE1
(nPE1core) (16) that are necessary for transgene expression in the
mouse hypothalamus (17) and conserved in most mammals (SI
Appendix, Fig. S1). To identify HDTFs that might recognize these
DNA elements, we took advantage of a comprehensive study that
determined the preferential DNA binding motifs of mouse home-
odomains (21). Based on their preferential binding, we assembled
a preliminary list of candidate HDTFs that was further trimmed
down by selecting those showing expression patterns compatible
with that of Pomc in the developing and/or adult ventromedial
hypothalamus by searching the mouse gene expression Allen Brain
Atlas (22). One particular candidate, the LIM-homeodomain TF
Islet1 (ISL1), immediately stood out from the rest because its ex-
pression pattern in this brain region accompanies that of Pomc from
its early onset and throughout the entire mouse life.
ISL1 Coexpresses with Pomc Since Its Early Onset at E10.5 to Adulthood.
To compare the expression patterns of Isl1 and Pomc, we per-
formed a detailed double immunofluorescence analysis in the
developing mouse brain using a rabbit polyclonal antibody raised
against the Pomc-derived peptide adrenocorticotropic hormone
(ACTH) and a mouse monoclonal antibody raised against ISL1.
At E9.5 we did not detect ISL1 or ACTH immunolabeled cells in
the developing hypothalamus, although ISL1 immunoreactive
cells were evident in the hindbrain (Fig. 1A). At E10.0, a few
ISL1+ cells are identifiable in the future hypothalamus, together
with a strong expression in the future Rathke’s pouch and in the
first pharyngeal arch, but no ACTH+ neurons are evident yet.
Coexpression of Isl1 and Pomc was observed at E10.5 and E12.5,
when every single ACTH+ neuron showed ISL1 nuclear labeling
(Fig. 1A, Insets), indicating that Pomc expression commences
a few hours later than the expression onset of Isl1 in the de-
veloping hypothalamus (Fig. 1A). ISL1+ cells accumulate in the
mantle zone of the developing hypothalamus where postmitotic
neurons are located (Fig. 1A), suggesting that Isl1 expression starts
in early postmitotic neurons before terminal differentiation.
Analysis of Isl1 and Pomc expression in the arcuate nucleus of
adult mice was performed using brain sections of Pomc-EGFP
transgenic mice (2) to overcome the high background signal that
most mouse monoclonal antibodies yield at this age. Immuno-
fluorescence using a rabbit anti-ISL1 antibody showed that ∼86%
of adult Pomc-EGFP+ neurons coexpress Isl1 (Fig. 1B). The ex-
pression pattern of Isl1 is much broader than that of Pomc in the
adult hypothalamus, where only 20% of ISL1+ hypothalamic
neurons coexpress Pomc-EGFP (Fig. 1B).
ISL1 Specifically Binds in Vitro and in Vivo to DNA Elements Present in
nPE1 and nPE2. We then examined the in vitro binding properties
of ISL1 in electrophoretic mobility shift assays (EMSAs) using
a bacterially expressed human ISL1 clone truncated in its LIM
domains, because it has been shown that these domains inhibit in
vitro DNA binding. We found that DNA probes encompassing
the canonical TAAT HDTF-binding site present in nPE1core,
nPE2 region 1, or nPE2 region 3 were shifted upon incubation
with ΔLIM-ISL1 bacterial extracts (Fig. 2A and SI Appendix, Fig.
S2). We then tested all possible individual ISL1 binding sites with
probes carrying inactivating mutations for each HDBS and found
Fig. 1. Isl1 is coexpressed with Pomc in the developing and adult mouse hy-
pothalamus. (A) Immunofluorescence analysis of ISL1 and ACTH expression in
sagittal cryosections at specified developmental stages. Insets are magnified
views and show that all ACTH+ cells express ISL1. H, future hypothalamus; RP,
future Rathke’s pouch; Hb, future hindbrain; PhA, first pharyngeal arch. (Scale
bar, 100 μm.) (B) Pomc coexpresses with Isl1 in adult mice. Anti-ISL1 immuno-
fluorescence was performed on coronal brain sections of Pomc-EGFP transgenic
mice. Arc, arcuate nucleus; 3V, third ventricle. (Scale bar, 100 μm.)
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that ΔLIM-ISL1 binds to both inverted TAAT motifs present in
nPE1core (Fig. 2 A and B). Differently, ΔLIM-ISL1 binds to only
one HDBS in region 1 and to another HDBS in region 3 of nPE2
(Fig. 2B and SI Appendix, Fig. S2).
The coexpression of Pomc and Isl1 prompted us to test whether
the interactions observed in vitro between ISL1 and nPE se-
quences in the EMSA studies are also found in vivo. To this end,
we used a mixture of two different anti-ISL1 antibodies in a chro-
matin immunoprecipitation (ChIP) assay using sheared chromatin
harvested from wild-type adult mouse hypothalami. The ISL1
antibodies pulled down nPE1 and nPE2 sequences, but not a re-
gion located between the enhancers (Fig. 2C). A control IgG
antibody, in contrast, failed to immunoprecipitate either nPE (Fig.
2C). Interestingly, we observed that LDB1, a LIM-only containing
protein often found to be a necessary cofactor of ISL1 in different
regulatory contexts (23, 24), also binds in vivo to nPE1 and nPE2,
but not to the region between them (Fig. 2C).
Functional Analysis of ISL1 Binding Sites in Transgenic Zebrafish and
Mice. To determine whether the TAAT motifs recognized by ISL1
have functional implications, we took advantage of our recent
finding that nPE1 as well as nPE2 can independently drive re-
porter gene expression specifically to hypothalamic POMC neu-
rons in transgenic zebrafish embryos (Fig. 3A) (25). To this end,
we built a series of transgenes carrying either wild-type or ISL1 BS
mutant versions (Isl1Mut) of nPE1 or nPE2, upstream of the
zebrafish pomca proximal promoter followed by EGFP coding
sequences (Tg1–Tg4; Fig. 3B). The zebrafish pomca proximal
promoter was used because it drives strong EGFP expression ex-
clusively to the pituitary and allows rapid selection of live zebrafish
embryos that integrated and expressed the transgenes 72 h post-
fertilization (hpf), as we have recently reported (25). Using this
transient expression assay we found that 36 of 119 (30.2%)
nPE1pomca-EGFP zebrafish embryos showing a bright green pi-
tuitary (Pit+) also showed hypothalamic EGFP expression (Tg1;
Fig. 3B). In contrast, only 10 of 120 (8.3%) Pit+ transgenic zebrafish
carrying nPE1(Isl1Mut)pomca-EGFP showed hypothalamic EGFP
expression (Tg2; Fig. 3B), indicating that the four point mutations
that disrupt the ISL1 BS present in nPE1 significantly reduced the
enhancer’s ability to drive reporter gene expression to hypothalamic
neurons. Similarly, 112 of 161 (69.5%) Pit+ nPE2pomca-EGFP
transgenic embryos showed positive neuronal enhancer activity
(Tg3; Fig. 3B), whereas hypothalamic EGFP expression sig-
nificantly dropped to 41% (66 of 159) in nPE2(Isl1Mut)pomca-
EGFP transgenic embryos, indicating that the two ISL1 binding
sites present in nPE2 contribute to the transcriptional strength
of this enhancer in the fish (Tg4; Fig. 3B).
To further test the importance of these ISL1 binding sites, we
generated transgenic mice carrying either the wild-type or Isl1Mut
versions of nPE1 or nPE2, upstream of the mouse proximal Pomc
promoter driving EGFP expression. The mouse proximal pro-
moter is included in these constructs because it has been shown to
drive reporter gene expression exclusively to POMC pituitary cells
and allowed us to discard transgenic pups carrying silent integra-
tions (15, 16). We found that the transgenes nPE1Pomc-EGFP
and nPE2Pomc-EGFP drove specific expression to POMC hypo-
thalamic neurons, as previously reported (16), whereas the mutant
versions nPE1(Isl1Mut)Pomc-EGFP and nPE2(Isl1Mut)Pomc-
EGFP completely failed to express EGFP in hypothalamic neu-
rons (Fig. 3 C and D) in three independent transgenic founder
mice that showed EGFP expression in the pituitary gland. Alto-
gether, our transgenic studies in zebrafish and mice indicate that
nPE1 as well as nPE2 function depend on the ISL1 binding sites to
fully drive reporter gene expression in hypothalamic neurons and
suggest that ISL1 is involved in neuronal Pomc expression.
Early Hypothalamic Pomc Expression Depends on ISL1. We have
shown above that the onset of Isl1 expression in the prospective
hypothalamus precedes that of Pomc by half a day, suggesting that
ISL1 participates in the initial transactivation of Pomc. To examine
this possibility, we sought to analyze Pomc expression in mice de-
ficient in Isl1. Because Isl1−/− mouse embryos die at E9.5 due to
impaired vascular development (26), we used Isl1loxP/loxP mice that
carry two loxP sites flanking the critical exon 2 (27) in combination
with mice ubiquitously expressing a tamoxifen (TAM)-inducible Cre
recombinase (CAAG-CreERT) (28). Pregnant Isl1loxP/loxP dams
previously crossed with Isl1loxP/loxP.CAAG-CreERT male mice were
injected at E9.5 with TAM to generate Isl1KO@E9.5 embryos
that were analyzed 2 d later (Fig. 4A). Analysis of Isl1KO@E9.5
embryos at E11.5 showed a normal overt morphology and size and
no evidence of tissue necrosis. Immunofluorescence performed on
sagittal sections of these embryos showed absence of Pomc ex-
pression (Fig. 4A) in contrast to what was observed in control sibling
embryos. Despite the lack of Pomc expression in Isl1KO@E9.5
embryos, the anatomy of the future hypothalamic and pituitary
areas remained unaltered (Fig. 4A). Specifically, no changes were
observed in the thickness of the hypothalamic neuroepithelium, the
morphology of the infundibulum, Rathke’s pouch, ventral mesen-
chyme, or other neighboring regions as found in other reported
HDTF null mice, such as Nkx2.1−/− or Rax−/− (29, 30). This ob-
servation suggests that the lack of ISL1 does not alter the expression
of genes involved in neurogenesis or general specification in the
prospective hypothalamus. To further confirm this hypothesis, we
followed the expression of Neurogenin 3 (Ngn3) and achaete-scute
Fig. 2. ISL1 binds to nPE1 and nPE2 sequences in
vitro and in vivo. (A) EMSA shows that ISL1 binds to
both HD-TFBS present in nPE1core. Four EMSA probes
were designed, one carrying the wild-type sequences
of both HD-TFBS (shown in green), and three carrying
either individual or simultaneous mutations of each
HD-TFBS (shown in red). Three lanes are shown for
each probe: 1, no protein; 2, control bacterial extract;
and 3, bacterial extract expressing ΔLIM-ISL1. The
white arrow indicates the high molecular weight
complex formed by ΔLIM-ISL1 and the nPE1 probe,
and the black arrow shows the lower molecular
weight complexes formed when only one HD-TFBS
remains intact. FP, free probe. A similar experiment
with nPE2 is shown in SI Appendix, Fig. S2. (B) Sche-
matic summary of the in vitro interactions between
ISL1 and nPE1core and nPE2 sequences. TAAT sites are
represented as boxes and those bound by ISL1 are
shown in green. Mutated nucleotides are shown in red for each site, and the region represented by the EMSA probes used in A is depicted. (C) ChIP assay with
adult mouse hypothalamus chromatin for testing in vivo binding of ISL1 and LDB1 to nPE1 and nPE2 sequences and a control region located between both nPEs in
the mouse Pomc locus (InternPEs). MM, molecular marker.
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complex like 1 (Ascl1) as molecular markers of early neurogenesis;
β-tubulin III (TUBIII), and calbindin 28-K (CALB) as markers of
differentiated neurons and Cleaved caspase 3 (CASP3) as a marker
of cell apoptosis, in Isl1KO@E9.5 embryos collected at E11.5
(Fig. 4A and SI Appendix, Fig. S3). We found that expression of the
proneuronal markers NGN3 and ASCL1 in the developing hypo-
thalamus at E11.5 was indistinguishable between control and
Isl1KO@E9.5 embryos, suggesting that the lack of ISL1 does not
affect neurogenesis in this brain region. Likewise, we did not find
significant differences in the expression of TUBIII or CALB be-
tween control and Isl1KO@E9.5 embryos, showing that lack of
ISL1 since E9.5 does not affect general differentiation of hypo-
thalamic neurons at E11.5. Regarding apoptotic activity, we de-
tected an increase in the amount of CASP3+ cells in Isl1KO@E9.5
embryos relative to controls (SI Appendix, Fig. S3). However, this
increase is not specific to the hypothalamus because it was ob-
served throughout the embryo, and even in mesenchymal tissue,
probably a sign of a defective vascular system in Isl1 mutant
embryos (26). To further test whether ISL1 is involved in the
development of other neuronal types, we studied the expression of
Orthopedia (Otp), a HDTF expressed in a small group of de-
veloping hypothalamic neurons that coexpresses Isl1 but not Pomc
(SI Appendix, Fig. S4) in Isl1KO@E9.5 embryos. Consistent with
our hypothesis, we found that Otp expression is absent in the hy-
pothalamus of Isl1KO@E9.5 embryos but not in the hindbrain,
where these two HDTFs do not coexpress (SI Appendix, Fig. S4).
Altogether, this molecular marker analysis indicates that Isl1 ab-
lation from the early steps of embryonic development prevents
the onset of Pomc expression without affecting the general de-
velopment of the future hypothalamus.
ISL1 Regulates Hypothalamic Pomc Expression Across Different Ages.
TFs that specify neuronal-subtype identities during embryonic de-
velopment may continue to drive cell-specific gene expression and
maintain postmitotic neuronal identities later in life (11). This may
be the case for ISL1 acting on POMC neurons because Isl1 and
Pomc coexpress in the ventral hypothalamus across the mouse
lifespan. To investigate whether Pomc expression depends on ISL1
at different ages, we treated Isl1loxP/loxP.CAAG-CreERT mice with
TAM at various time points and analyzed hypothalamic Pomc ex-
pression. We first gave TAM to pregnant dams carrying E11.5
embryos, a time point in which hypothalamic Pomc expression
has already started and analyzed Isl1KO@11.5 embryos at E15.5.
Although this TAM treatment produced a drastic, but incomplete,
reduction in ISL1 levels, hypothalamic Pomc expression was not
detected in Isl1 knockdown E15.5 embryos (Fig. 4B). Interestingly,
Pomc expression in the pituitary remained intact (Fig. 4B). Lack of
hypothalamic Pomc expression does not seem to be a consequence
of a drop in the number of mature neurons, because CALB and
TUBIII are normally expressed in these embryos (Fig. 4B). These
results demonstrate that hypothalamic Pomc expression completely
depends on ISL1 during the first stages of mouse development,
from its early onset at E10.5 to at least E15.5.
To investigate the importance of ISL1 in Pomc expression after
birth, we treated Isl1loxP/loxP.CAAG-CreERT mice with TAM for
5 consecutive days, starting at postnatal day 21 (P21) or at 3 mo
old (P90). A month later, we measured the levels of hypothalamic
Isl1 and Pomc mRNAs by qRT-PCR and found that our injection
protocol was highly efficient, yielding a reduction of ∼90% of
hypothalamic Isl1 mRNA. Isl1@P21 and Isl1@P90 knockdown
mice exhibited around 40% of hypothalamic Pomc mRNA levels
relative to control Isl1loxP/loxP mice (Fig. 4C). In summary, these
results indicate that ISL1 is required for maintaining normal levels
of hypothalamic Pomc expression during pre- and postnatal life.
Role of Ascl1 and Ngn3 in the Ontogeny of Hypothalamic ISL1/POMC
Neurons. During neurogenesis, the progenitor cells that become com-
mitted to a neuronal fate express TFs of the basic helix–loop–helix
Fig. 3. ISL1 binding sites in nPE1 and nPE2 are important for enhancer function. (A) Schematic of a 72-hpf zebrafish head showing the distribution of pomca-
expressing cells (red dots) in the pituitary (Pit) and hypothalamus (Hyp). For transient reporter gene expression analyses, transgenic embryos showing strong pi-
tuitary EGFP expression (Pit+) at 72 hpf are selected and then sorted as expressing (Hyp+) or not expressing (Hyp−) EGFP in the hypothalamus. (Scale bar, 50 μm.)
(B) Expression analyses of transgenes driving EGFP under the control of zebrafish proximal pomca sequences (from −0.6 to +0.4 kb, in gray) and a neuronal mouse
Pomc distal module carrying either wild-type or Isl1Mut enhancers nPE1 (red box) or nPE2 (blue box) in transgenic zebrafish. Seventy-two hours postfertilization,
transgenic embryos were selected based on pituitary EGFP expression (Pit+), and the number of Pit+ embryos also showing EGFP+ neurons in the hypothalamus
(Hyp+) was quantified. #P < 0.0001, χ2 test. (C) Expression analysis of transgenic mice carrying nPE1 or nPE1 (Isl1Mut) sequences driving EGFP on coronal sections at the
hypothalamic arcuate (Arc) level. (D) Expression analysis of transgenic mice carrying nPE2 or nPE2 (Isl1Mut) sequences driving EGFP on coronal sections at the hypo-
thalamic arcuate (Arc) level. 3V, third ventricle. (Scale bar, 500 μm.)
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(bHLH) family, known as proneural genes (31). In the mouse
hypothalamus, it has been shown that the proneural genes Ascl1
and Ngn3 are necessary for hypothalamic neurogenesis and, more
specifically, Ascl1−/− as well as Ngn3−/− mutant mice have a re-
duced number of hypothalamic POMC neurons (32, 33). During
development, we observed by immunofluorescence that NGN3
and, specially, ASCL1 are mainly found near the ventricular zone
of the future hypothalamus, where neuronal progenitors reside,
whereas ISL1 is expressed mainly in the mantle zone, where post-
mitotic differentiated neurons accumulate (SI Appendix, Fig. S5).
We observed that ASCL1 and ISL1 colocalize in cells present
within a stripe located between the ventricular and mantle zones,
whereas the colocalization between NGN3 and ISL1 in this region
is complete (SI Appendix, Fig. S5).
To study the role of these proneural genes in Isl1 expression,
we analyzed Ascl1- and Ngn3-deficient mice at E11.5 by
immunofluorescence and found that both Ascl1−/− and Ngn3−/−
embryos have only a few POMC neurons in the hypothalamus, as
previously described (32, 33). The number of ISL1+ neurons is also
greatly reduced in Ascl1−/− embryos, reaching 10% of wild-type
levels. Interestingly, however, Ngn3−/− embryos still have normal
numbers of ISL1+ neurons (Fig. 5A). Ascl1−/−.Ngn3−/− double mu-
tant E11.5 embryos showed a complete absence of POMC immu-
noreactivity, although the number of ISL1+ cells was similar to that
Fig. 4. Hypothalamic Pomc expression is impaired in Isl1 conditional knockout mice. (A) Immunofluorescence analysis of the specified molecular markers in
sagittal cryosections of Isl1KO@E9.5 and control embryos at E11.5. Isl1 deficiency prevents hypothalamic Pomc expression onset without severely affecting the
expression of neurogenin 3 (NGN3), achaete-scute complex like 1 (ASCL1), calbindin 28-K (CALB), or β-tubulin III (TUBIII). H, future hypothalamus; RP, future
Rathke’s pouch. DAPI staining is shown in blue. (Scale bar, 100 μm.) (B) Isl1 function is required for maintaining hypothalamic Pomc expression. Immunofluo-
rescence analysis of the specified molecular markers in sagittal cryosections of Isl1KO@E11.5 and control embryos at E15.5. ISL1 deficiency prevents Pomc ex-
pression in the hypothalamus but not in the pituitary (Pit). H, future hypothalamus; Hb, hindbrain. DAPI staining is shown in blue. (Scale bar, 100 μm.) (C) Isl1 is
necessary for hypothalamic postnatal Pomc expression. qRT-PCR of Isl1 and Pomc mRNAs obtained from Isl1KO@P21 mouse hypothalami at 7 wk old, relative to
control group (Isl1loxP/loxP). AU, arbitrary units. n = 3 for each group. Error bars correspond to SEM. #P < 0.0001, *P < 0.05, Student’s t test.
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found in Ascl1− /− embryos (Fig. 5A). In summary, our results
show that Isl1 is epistatically downstream of Ascl1 but not of Ngn3
(Fig. 5B), and that in the absence of Ngn3, Isl1 is unable to sustain
normal Pomc expression during hypothalamic development.
Selective Elimination of ISL1 in POMC Neurons Causes Early-Onset
Obesity. The ubiquitous loss of ISL1 function during development
produces a lethal phenotype that prevents further physiological
studies in adult mice. To circumvent this limitation we sought to
abolish Isl1 expression exclusively from POMC neurons by crossing
Isl1loxP/loxP mice with Pomc-Cre mice (34), a BAC transgenic line
expressing Cre recombinase from mouse Pomc regulatory regions.
Because Isl1 is not expressed in pituitary POMC cells, compound
PomcIsl1KOmice lack Isl1 expression exclusively in POMC arcuate
neurons starting at day E10.5. Analysis of hypothalamic Pomc
mRNA levels in PomcIsl1KO and control Isl1loxP/loxP mice by
qRT-PCR showed that PomcIsl1KO mice have ∼25% of hypo-
thalamic Pomc mRNA levels in comparison with control mice
(Fig. 6A). An immunofluorescence study performed in coronal
mouse brain sections confirmed a marked reduction in ACTH
immunoreactivity in the arcuate nucleus, but not in the pituitary,
of PomcIsl1KO mice in comparison with their control Isl1loxP/loxP
siblings (Fig. 6B). A distinctive feature of central Pomc deficiency is
early-onset obesity induced by hyperphagia (4). Analysis of food
intake and body weight curves of PomcIsl1KO mice fed ad libitum
with standard low-fat chow showed that male and female
PomcIsl1KO mice are hyperphagic and display early-onset obe-
sity compared with their Isl1loxP/loxP siblings (Fig. 6 C andD), which,
in turn, showed identical growth curves to wild-type Isl1+/+ mice
(SI Appendix, Fig. S6). We also observed an increased linear
growth in PomcIsl1KO male mice (SI Appendix, Fig. S6). Body
fat distribution in PomcIsl1KO mice at 5 mo of age showed that
the increased body weight is largely due to an exaggerated fat
deposition in visceral and s.c. fat pads (Fig. 6 E–G). As a result of
increased adiposity, fast serum leptin levels increased consider-
ably, as observed in 4-mo-old PomcIsl1KO mice compared with
controls (Fig. 6H). The phenotypes observed in PomcIsl1KO
mice are reminiscent of those previously reported in Pomc-deficient
mice (4, 35). Chronic and excessive accumulation of adipose tissue
may lead to a generalized health disorder known as metabolic
syndrome, which includes the development of a fatty liver and type
II diabetes. In fact, liver size was increased in PomcIsl1KO mice of
both sexes (Fig. 6I) although fast blood glucose and serum insulin
levels were normal in these mice (SI Appendix, Fig. S6). To confirm
that the phenotypes observed in PomcIsl1KOmice are solely due to
the loss of ISL1 in POMC neurons, we sought to rule out the
possible ectopic expression of cre in Pomc-Cre mice, especially in
pancreatic islets where Isl1 regulates the maturation, proliferation,
and survival of the endocrine pancreas (36). To this end, we crossed
Pomc-Cre mice with the Cre reporter strain Ai14 that activates the
expression of a red fluorescent protein upon Cre-mediated re-
combination. In contrast to the numerous bright red cells observed
in the hypothalamus and the pituitary, we did not find any red cell
in pancreatic islets of compound Pomc-Cre.Ai14 mice (SI Appendix,
Fig. S7), demonstrating that Pomc-Cre mice are indeed a selective
tool for this study. Overall, our results demonstrate that Isl1 ex-
pression in POMC hypothalamic neurons plays a fundamental role
in normal body weight homeostasis by controlling hypothalamic
Pomc expression in adulthood.
The regulation of Pomc by Isl1 Is an Ancient Feature in Vertebrates.
Because ISL1 is found in the zebrafish hypothalamus, we decided
to investigate whether the regulation of Pomc expression by Isl1
observed in the mouse is conserved in an evolutionary distant
vertebrate. Teleost fishes have two Pomc paralogs named pomca
and pomcb (25). Whereas pomca is expressed in the pituitary and
in hypothalamic neurons of the nucleus lateralis tuberis (NLT), the
homolog structure to the mammalian arcuate nucleus, pomcb is
expressed in the brain preoptic area. Using double immunofluo-
rescence, we observed that 92% of POMC hypothalamic neurons
located in the zebrafish NLT also express ISL1 at 72 hpf (Fig. 7A).
As we observed in the mouse hypothalamus (Fig. 1), the expression
territory of ISL1 in the zebrafish NLT is much broader than that
of pomca. To study the role of ISL1 in pomca transcription, we
Fig. 5. Role of bHLH TFs on Isl1 hypothalamic expression during development. (A) Immunofluorescence analysis of ISL1 (green) and Pomc-derived ACTH (red)
expression in Ascl1−/−, Ngn3−/−, and Ascl1−/−.Ngn3−/− mutant E11.5 embryos. H, future hypothalamus. (Scale bar, 100 μm.) (B) Schematic of regulatory
interactions of TFs involved in Pomc expression in the developing hypothalamus. ASCL1 is required in early steps of hypothalamic neurogenesis to activate
Ngn3 and Isl1 expression. These two TFs may independently activate Pomc expression. NGN3 may directly transactivate Pomc as a pioneer factor (green arrow)
and/or by activating an intermediate TF of unknown identity, represented by a question mark.
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microinjected zebrafish embryos with antisense morpholino oligo-
nucleotides (MOs) designed to block isl1mRNA translation (37) and
the results were compared with embryos microinjected with vehicle
or with a heterologous morpholino (het-MO) of a similar length and
nucleotide composition to that of the Isl1-MO. At 72 hpf, Isl1
morphant embryos (Isl1-MO) have reduced body size, curled down
tail, and defective heart development (Fig. 7A), in agreement with
phenotypes previously reported for isl1 mutant zebrafish lines (38).
Analysis of isl1 expression by immunofluorescence showed a great
reduction of ISL1 in Isl1-MO embryos in comparison with both
control groups, although the overall anatomy of the ventral hypo-
thalamus remained normal (Fig. 7B). In addition, ISL1 knockdown
zebrafish embryos showed an almost complete loss of pomca ex-
pression in the hypothalamus but not in the pituitary, as shown by
immunofluorescence and whole mount in situ hybridization (Fig. 7 B
and C). The effect of ISL1 on pomca expression is specific because
the levels of pomcb mRNA in the preoptic area and those of the
hypothalamic neuropeptide gene agrp remained unaltered in Isl1-
MO microinjected zebrafish embryos (Fig. 7B).
Previously in this work, we have shown that the ability of mouse
nPE1 and nPE2 sequences to drive EGFP expression to hypo-
thalamic POMC neurons in transgenic zebrafish is impaired when
the ISL1 binding sites are mutated (Fig. 3B), suggesting that
zebrafish ISL1 binding to the mouse enhancers plays an important
role for transactivating the reporter gene in this specific neuronal
population. To further test this hypothesis, we microinjected Isl1-
MO in embryos obtained from a stable line of transgenic zebrafish
harboring a 4-kb mouse sequence encompassing nPE1 and nPE2
upstream of the pomca pituitary promoter followed by EGFP (25).
We found that transgenic embryos receiving Isl1-MO were unable
to express EGFP in the hypothalamus, but retained bright green
fluorescent cells in the pituitary in contrast to zebrafish embryos
microinjected with vehicle or the het-MO, which showed EGFP
expression in POMC neurons as well (SI Appendix, Fig. S8). Al-
together, these results indicate that ISL1 is a positive regulator of
Fig. 6. ISL1-specific deletion in POMC neurons causes early onset obesity. (A) Hypothalamic Pomc mRNA expression normalized to 18S rRNA, relative to
Isl1loxP/loxP, in arbitrary units (AU). (B) Immunofluorescence analysis of Pomc expression (ACTH, red) in coronal sections of adult hypothalamus. Arc, arcuate
nucleus; Pit, pituitary; 3V, third ventricle. (Scale bars, 100 μm.) (C) Average daily food intake measured during 3 consecutive weeks at 3 mo of age. (D) Body
weight curves of Isl1loxP/loxP and PomcIsl1KO male and female mice. PomcIsl1KO mice are obese (RMA, genotype × time effect. #P < 0.0001 for PomcIsl1KO vs.
Isl1loxP/loxP for both sexes). (E–G) Determination of inguinal, gonadal, and retroperitoneal fat pad and liver (I) weights in Isl1loxP/loxP and PomcIsl1KO 5-mo-old
mice. (H) Fasting serum leptin levels were determined in 4-mo-old mice. (J) A representative obese PomcIsl1KO male mouse and a normal Isl1loxP/loxP sibling at
5 mo of age. Values represent mean ± SEM (n = 5–8). *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t test).
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hypothalamic Pomc transcription in zebrafish and mice and reveal
that at least part of this regulation is ancestral to all jawed verte-
brates, having been established before the evolutionary divergence
of tetrapods and teleost fishes, around 450 Mya.
Discussion
In this study we combined molecular, genetic, physiological, and
evolutionary approaches to demonstrate that the LIM-homeodomain
transcription factor ISL1 directly regulates the neuronal expression of
Pomc in the vertebrate hypothalamus. Specifically, we show that:
(i) Isl1 is expressed in POMC hypothalamic neurons during embry-
onic development and adulthood; (ii) ISL1 binds in vitro and in vivo
to DNA elements present in the Pomc neuronal enhancers nPE1 and
nPE2, which are important for enhancer function; (iii) Isl1 expression
is necessary for hypothalamic Pomc expression during embryogenesis;
(iv) Isl1 deficiency in the adult hypothalamus causes reduced Pomc
expression and an energy balance phenotype including obesity; and
(v) the regulation of Pomc by Isl1 is an ancient feature in vertebrates.
Several transcription factors are known to confer regional identity
to the early hypothalamic anlage, regulate neurogenesis, and de-
termine neuronal identity in specific hypothalamic nuclei (39). ISL1
is neither expressed during early forebrain patterning nor in hypo-
thalamic progenitors, but rather in maturing and fully mature hy-
pothalamic neurons. This and our conditional knockout results
point to ISL1 being a terminal differentiation gene that is necessary
to establish the specific identity of POMC neurons after these cells
are born and accumulate in the mantle zone, giving rise to the ar-
cuate nucleus. Recent work has shown that Isl1 plays pivotal roles in
determining the cell fate of GABAergic medium spiny striatofugal
neurons (40), cholinergic magnocellular striatal interneurons (41),
and cholinergic spinal and cranial motor neurons (42). Interestingly,
these different ISL1-dependent neuronal types participate in pyra-
midal and extrapyramidal circuits that coordinate body movement
and locomotion. Besides its importance in the motor system, Isl1
also participates in the differentiation and maintenance of cell
types involved in the physiology of metabolism. For example, Isl1 is
expressed in pancreatic islets where it is required for the matura-
tion, proliferation, and survival of the endocrine pancreas (36). Our
results showing that Isl1 is essential for the neuronal expression of
the satiety gene Pomc in the ventromedial hypothalamus adds an-
other neuronal type to the category of ISL1-dependent cells in-
volved in the regulation of metabolism and energy balance. In this
work, we show that ISL1 is also necessary for the expression of the
hypothalamic TF orthopedia (Otp) in the future arcuate nucleus,
indicating that the function of ISL1 in this brain region is not re-
stricted to the POMC lineage (SI Appendix, Fig. S4).
Consistent with its terminal specification function, ISL1 does
not control general neuronal differentiation, because β-tubulin
and calbindin expression appear to be normal in conditional Isl1
mutants. This is also consistent with the fact that Isl1 is epistatically
downstream of one hypothalamic proneural gene, namely ASCL1.
The proneural bHLH factors ASCL1 and NGN3 are expressed in
neuronal progenitors in the developing hypothalamus since E9.5
and play a role in general neurogenesis as well as in the specifi-
cation of some hypothalamic neuronal populations, including
those that express POMC (32, 33). In contrast to ISL1, both
bHLH factors are expressed only transiently during hypothalamic
neurogenesis and are not present in mature POMC neurons
Fig. 7. ISL1 regulates hypothalamic pomca expression in zebrafish. (A) Schematic of a 72-hpf zebrafish head in a horizontal plane showing the distribution of
pomca-expressing cells in the pituitary and hypothalamus (red dots). The blue rectangle depicts the magnified area shown in the other panels. Double immuno-
fluorescence analysis showing pomca (ACTH, red) and isl1 (green) coexpression in horizontal sections of 72-hpf zebrafish brain. (B, Left) Phenotypic characterization
of 72-hpf Isl1-MO, het-MO, and vehicle-injected zebrafish. Isl1-MO larvae have reduced body size, curved down tail, and develop cardiac edema (indicated with an
arrow in magnified Inset). (Right) Molecular characterization of the hypothalamus in Isl1-MO, het-MO, and vehicle-injected zebrafish embryos. Immunofluorescence
(IF) analysis in horizontal brain sections of 72-hpf zebrafish shows that ISL1 knockdown completely eliminates pomca expression (ACTH) in the hypothalamus, but
not in the pituitary. Whole-mount in situ hybridization (ISH) further confirms the lack of pomca expression in the brain and shows that other hypothalamic markers,
pomcb and agrp, remain unchanged in Isl1-MO relative to control embryos. Hyp, hypothalamus; Pit, pituitary. (Scale bars, 50 μm.) (C) Quantification of the total
number of ACTH+ neurons per embryo in Isl1-MO (n = 16)-, het-MO (n = 15)-, and vehicle (n = 28)-injected zebrafish. Bars correspond to mean + SEM. ***P < 0.001,
Student’s t test vs. vehicle.
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(32, 33). Here we show that Isl1 expression depends on ASCL1, but
not on NGN3. Thus, it can be envisaged that the importance of
ASCL1 in the specification of POMC neurons is due, at least in
part, to its role in the expression of ISL1. In contrast to what has
been observed in pancreatic islets (43), NGN3 is not necessary for
the expression of ISL1 in the hypothalamus, even though it is also
downstream of ASCL1 (33). Thus, in the hypothalamus, NGN3 and
ISL1 seem to act in parallel to regulate Pomc expression. The
proposed relationship between ISL1 and the bHLH factors is
depicted in Fig. 5B. Because NGN3 is only transiently expressed in
the POMC lineage (33), it is possible that this bHLH factor is
necessary for the expression of another TF which, in its turn, is
required for full Pomc expression. Alternatively, NGN3 could act
as, or corecruit, a pioneer transcription factor that might render the
Pomc gene transcriptionally competent.
In recent years, it has become evident that cell-specific expression
of some metazoan genes may be controlled by two or more regu-
latory regions displaying similar transcriptional activities (44, 45).
Such apparently redundant enhancers have been best studied in
Drosophila, where enhancers with similar activities recruit similar
sets of TFs (46). This phenomenon of enhancer redundancy, how-
ever, has not been characterized in mammals at the molecular level.
nPE1 and nPE2 drive identical reporter expression patterns in
transgenic mice (16) and, by targeted mutagenesis in mice, we have
recently shown that both enhancers are necessary for full endoge-
nous Pomc expression in the hypothalamus (17). Similar to what has
been found for redundant enhancers in Drosophila, we found that
ISL1 binds to DNA elements present in both nPE1 and nPE2, and
that these elements are needed for hypothalamic enhancer function.
Thus, the similar regulatory activities of nPE enhancers are con-
ferred by the binding of at least one common TF. This observation
is even more striking as nPE1 and nPE2 are not the result of
a segmental duplication but have originated as separate events of
cooption (“exaptation”) of retroposon sequences during mamma-
lian evolution (16, 18), implying that the exaptation process involved
the independent acquisition of similar TF binding sites by each
transposon.
Isl1 is an ancient gene, present in the genomes of basal meta-
zoans like cnidarians, ctenophores, and placozoans (47). In some
systems, like second heart field and somatosensory neurons, Isl1
expression is part of a transcriptional signature conserved in inver-
tebrates and vertebrates (48). Pomc, on the other hand, is only found
in vertebrates, being expressed in the hypothalamus of all jawed
vertebrates. Our observation that Isl1 is expressed in the zebrafish
hypothalamus and that it is necessary for pomca expression indicates
that ISL1 has been part of the POMC neuron transcriptional code
since the appearance of this neuronal subtype in the ancestor of
teleosts and tetrapods, around 450Mya. This is reinforced by the fact
that mouse nPEs can drive expression to zebrafish pomca neurons
(25) and that zebrafish ISL1 is also necessary for this activity. In-
terestingly, we observed that the expression of the zebrafish paralog
pomcb in the preoptic area does not depend on ISL1. Thus, our
results show that the expression of the two zebrafish Pomc paralogs
depend on a different cis/trans-transcriptional code and indicate that
only the primitive tuberal hypothalamic POMC population was
controlled by ISL1 in the vertebrate ancestor, which is consistent
with the fact that mouse nPE enhancers can drive expression to the
pomca territory, where zebrafish ISL1 is abundantly expressed, but
not to the pomcb territory in the preoptic area (25).
POMC-derived melanocortins and their central receptors play
a crucial role in the regulation of food intake and energy balance
in adult vertebrates, including humans (1). Moreover, mice and
humans lacking POMC or the melanocortin 4 receptor (MC4R) are
extremely hyperphagic and obese (5, 35, 49, 50). Despite the fact
that genetic factors explain up to two-thirds of body weight and fat
mass variation in the human population, monogenic cases of obe-
sity are rarely seen in the clinic. Recent genome-wide association
studies (GWASs) suggest that obesity follows a polygenic continu-
ous trait model in which many frequent polymorphic alleles, each
providing a very small effect, act in combination to increase the
predisposition to gain more fat. Alternatively, the risk for obesity
may increase after the concomitant occurrence of a few low-fre-
quency variants, each providing strong or intermediate effects. Our
findings showing that depletion of ISL1 specifically in POMC
neurons induces obesity may be of biomedical relevance because
polymorphisms in regulatory regions leading to low levels of
Isl1 expression in the ventral hypothalamus may impair Pomc
expression and compromise the normal control of food intake
and energy balance.
Materials and Methods
Animal Care. Mice were housed in ventilated cages under controlled tem-
perature and photoperiod (12-h light/12-h dark cycle, lights on from 7:00
AM to 7:00 PM), with tap water and laboratory chow containing 28.8%
protein, 5.33% fat, and 65.87% carbohydrate available ad libitum. All
mouse procedures followed the Guide for the Care and Use of Laboratory
Animals (51) and in agreement with the Institutional Animal Care and Use
Committee of Instituto de Investigaciones en Genética y Biología Molec-
ular (INGEBI) and the University Committee on the Care and Use of Ani-
mals of the University of Michigan.
Breeding of Mice. Animals carrying the Isl1loxP allele (27) were obtained from
L. Gan, University of Rochester, Rochester, NY, and maintained in our laboratory
as homozygotes on a mixed background. CAAG-CreERT mice (28) were obtained
from The Jackson Laboratory (B6.Cg-Tg[CAG-cre/Esr1]5Amc/J) and were inter-
crossed with Isl1loxP/loxP mice to generate the TAM-inducible Isl1 conditional
knockout strain CAG-CreERT.Isl1loxP/loxP. Pomc-cre mice (34) were obtained from
G. S. Barsh, Stanford University School of Medicine, Stanford, CA, and were
maintained in our laboratory as heterozygotes on a mixed background. Animals
with POMC-specific Isl1 deletion (PomcIsl1KO) were generated by intercrossing
Isl1loxP/loxP with Pomc-cre mice. The cre reporter line Ai14 (52) and Ascl1−/− (53)
and Ngn3−/− (43) embryos were a gift from G. Lanuza, Instituto de Inves-
tigaciones Bioquímicas de Buenos Aires, Buenos Aires, Argentina.
Transgenes and Transgenic Mice Production. Transgenes nPE1Pomc-EGFP
and nPE2Pomc-EGFP were previously reported (15, 16). Transgenes nPE1
(Isl1Mut)Pomc-EGFP and nPE2 (Isl1Mut)Pomc-EGFP are identical to the ones
above except they carry four point mutations that disrupt the ATTA HDBS
recognized by ISL1. These mutations were introduced in the enhancer sequence
by a standard megaprimer PCR protocol and confirmed by DNA sequencing
(primer information is available in SI Appendix, Table S1). More details are
provided in SI Appendix, SI Materials and Methods.
Reporter Gene Expression in Transgenic Mice. Transgenic pups were killed,
heads were fixed overnight in paraformaldehyde 4% (wt/vol) in PBS and then
cryoprotected in sucrose 10% (wt/vol) in PBS for another 24 h. Tissue was em-
bedded in a solution of 10% (wt/vol) sucrose with 10% (wt/vol) gelatin in PBS,
snap frozen in isopentane cooled to −60 °C in dry ice and stored at −80 °C.
Coronal 20-μm-thick sections were cut in a cryostat (Leica 1510S) and collected
on Super-Frost Plus slides (Fisher Scientific). Sections were directly visualized or
incubated with primary rabbit polyclonal antibody anti-GFP (ab290, Abcam).
Immunofluorescence. Sagittal (14 μm for E9.5–E12.5 and 18 μm for E15.5) sec-
tions were obtained in a cryostat (Leica 1510S) and collected on Super-Frost Plus
slides (Fisher Scientific). More experimental details are provided in SI Appendix,
SI Materials and Methods and for additional information of antibodies used in
this study see SI Appendix, Table S2.
Tamoxifen Treatment. TAM (T56648, Sigma-Aldrich) was dissolved in sesame oil
(S3547, Sigma-Aldrich) at 10 mg·mL−1. For treatment in the embryo, one single
dose of TAM (130 μg per gram of body weight) was given to the mother by
i.p. injection. For treatment in juvenile and adult mice, five single daily doses of
TAM (70 μg per gram of body weight) were given by i.p. injection during 5
consecutive days.
Hypothalamic mRNA Quantification. Hypothalamic total RNA was prepared
with TRIzol (Invitrogen) and then treated with RNase-free DNaseI (Ambion).
First-strand cDNA synthesis was generatedwith random primers using a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Pomc mRNA
was identified by relative quantitative RT-PCR using TaqMan gene expres-
sion assay (Mn00435874_M1, Applied Biosystems) and normalized to 18S
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rRNA (HS99999901_S1, Applied Biosystems) (4). Isl1 mRNA was identified by
relative qRT-PCR using SYBR Select Master Mix (Applied Biosystems) and
normalized to mouse cyclophilin B mRNA. Primer information is available in
SI Appendix, Table S1. Samples were run on a Rotor-Gene 6000 instrument
(Corbett Life Science) or Opticon2 (MJ Research), and results were analyzed
by the 2-ΔΔCT relative quantitation method (54).
Statistics. All data presented are the mean ± SEM and were analyzed by
repeated measures ANOVA or Student’s t test unless otherwise stated
using Statistica. Post hoc pairwise comparisons between groups were
performed by Fisher’s least significant difference post hoc test. P values
less than 0.05 were considered significant.
Zebrafish Husbandry. Adult AB zebrafish stocks (Zebrafish International Re-
source Center) were raised and maintained at 28.5 °C under a 14:10-h light:
dark cycle. Embryos were collected soon after natural spawning and raised
in zebrafish embryonic E3 media (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,
0.33 mM MgSO4, 10
−5% methylene blue) in Petri dishes kept at 28.5 °C.
Larvae to be used for in vivo screenings or whole-mount in situ hybridization
were grown in E3 buffer containing 0.2 mM 1-phenyl-2-thiourea (PTU) from
1 d postfertilization.
Further detailed descriptions of all materials and methods are provided in
SI Appendix, SI Materials and Methods.
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